The Skolkovo Foundation will participate in 2014 BIO International Convention, the international biotechnology exhibition, which will take place in San Diego, USA on 23-26 June 2014. As the world’s largest biotechnology gathering BIO 2014 will bring together major pharmaceutical companies, startups and influential decision-makers from the biotech industry.

This year Skolkovo will present 7 perspective startups from the Biomed Cluster, which develop new diagnostics and targeted drugs for oncology treatment and stem cells regenerative technologies.

Kirill Kaem, Executive Director of the Skolkovo Foundation Biomedical Technologies Cluster, commented that: ‘This is an important biotech road-show of Skolkovo resident companies to the US. At BIO 2014 Skolkovo Foundation will be looking for cooperation opportunities with the global biopharmaceutical community along the two lines, including cross-scouting of startup projects and exploring the potential for locating biotech R&D centers in Skolkovo and in Russia.’

Skolkovo will exhibit its residents at the Russian booth #5423. The full list of participants from Skolkovo Foundation includes the following startups:


Fusion Pharma Small molecule drug candidate against chronic myelogenous leukemia (CML) including its drug resistant forms
Quantum Pharm New drug applications from a novel computational molecular modeling platform that reduces the time in obtaining research results – anti-cancer agent and next generation therapy of AIDS
Inkuron Pre-clinical and clinical trials of innovative drugs based on a new class of molecules, Curaxins – small molecules with potentially wide range of therapeutic use for cancer and autoimmune disease treatment
OncoTartis Portfolio anticancer drugs under development based on novel scientific concept of ‘anti-tissue chemical surgery’
RosGenDiagnostics Technology for cancer diagnostics and personalized treatment based on tumor molecular profile
CL Oncology Development of anti-tumor viruses, a family of revolutionary products for oncology patients that will prolong their lives and facilitate remission and/or complete recovery
JoinTechCell Device for extracting stem cells from fat tissues


About the Skolkovo Foundation

The Skolkovo Foundation is a non-profit organization founded in September 2010 by the Russian government with an objective to accelerate transformation of Russia from a resource-intensive to an innovation-based economy. To achieve this objective the Foundation is overseeing the creation of the Skolkovo Innovation Center composed of companies and startups, developing innovative technologies (currently numbering over 1000), a Technopark, the Skolkovo Institute of Technology (Skoltech), a new graduate research University established in collaboration with the Massachusetts Institute of Technology, and Skolkovo city, located near Moscow. Together these entities will establish a vibrant ecosystem of technology innovation and entrepreneurship. 30 world’s most successful corporations, including Boeing, Cisco Systems, EADS, GE, Johnson & Johnson, IBM, Intel, Microsoft, Siemens, Nokia, Samsung etc. have already recognized the opportunity Skolkovo presents having signed R&D partnership agreements with the Foundation. For more information: 


Press contacts:

Taisiya Yarmak
Tel.: +7 (495) 967 01 48 ext. 2310
Fax: +7 (495) 967 01 96